Boston Cell Standards Inc

Boston Cell Standards develops calibration and quality control products for immunohistochemistry (IHC) testing, a diagnostic method used in cancer diagnosis. The company offers IHCalibrators and IHControls products designed to standardize and improve the accuracy of cancer diagnostic assays, and is working with the FDA to qualify its Metric quality platform as the first standardized system for IHC testing.